A Prospective Study of Febrile Neutropenia in Pediatric Cancer Patients in Jordan

被引:11
作者
Al Omar, Suha [1 ]
Nazer, Lama [1 ]
Alkayed, Khaldoun [2 ]
机构
[1] King Hussein Canc Ctr, Dept Pharm, Amman 11941, Jordan
[2] King Hussein Canc Ctr, Dept Pediat, Amman 11941, Jordan
关键词
fever; neutropenia; pediatrics; oncology; outcome; CHEMOTHERAPY-INDUCED NEUTROPENIA; ANTIMICROBIAL AGENTS; CHILDREN; EPISODES; FEVER; INFECTION; MORTALITY; ONCOLOGY;
D O I
10.1097/MPH.0b013e31829f3480
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective:To describe the characteristics and clinical course of febrile neutropenia (FN) in pediatric patients admitted to a comprehensive cancer center in Jordan.Methods:This is a 6-month prospective observational study. Patients admitted with FN were identified. Patient demographics, duration since last chemotherapy, use of granulocyte colony-stimulating factor, presence of central lines, transfer to the intensive care unit, length of hospital stay, mortality, and the results of all cultures were recorded.Results:One hundred and nine episodes for 88 patients were included, with a median age of 6 years (range, 1 to 19 y) and 55% were females. Median duration since last chemotherapy was 7 days (range, 1 to 33 d); median duration of hospital stay was 7 days (range, 1 to 81 d). Transfer to the intensive care unit was required for 11% of episodes, and there were no deaths. Positive cultures were reported in 18.4% episodes. Pathogens isolated were gram-positive organisms (50%), gram-negative organisms (20%), viral (25%), and fungal (5%). Positive blood cultures were significantly more in episodes with central lines compared with those with no central lines (P=0.04).Conclusions:FN episodes had favorable outcomes and were mostly associated with negative cultures. There were differences between the microbiologic profiles reported in this study, compared with what has been previously described.
引用
收藏
页码:614 / 617
页数:4
相关论文
共 17 条
[1]   SEPTICEMIA IN FEBRILE NEUTROPENIC CHILDREN WITH CANCER IN SAUDI-ARABIA [J].
ALFAWAZ, IM ;
KAMBAL, AM ;
ALRABEEAH, AA ;
ALRASHEED, SA ;
ALEISSA, YA ;
FAMILUSI, JB .
JOURNAL OF HOSPITAL INFECTION, 1991, 18 (04) :307-312
[2]  
Ariffin H, 2002, INT J CLIN PRACT, V56, P237
[3]   Length of stay and mortality associated with febrile neutropenia among children with cancer [J].
Basu, SK ;
Fernandez, ID ;
Fisher, SG ;
Asselin, BL ;
Lyman, GH .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :7958-7966
[4]   A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation [J].
Castagnola, Elio ;
Fontana, Vincenzo ;
Caviglia, Ilaria ;
Caruso, Silvia ;
Faraci, Maura ;
Fioredda, Francesca ;
Garre, Maria Luisa ;
Moroni, Cristina ;
Conte, Massimo ;
Losurdo, Giuseppe ;
Scuderi, Franca ;
Bandettini, Roberto ;
Toma, Paolo ;
Viscoli, Claudio ;
Haupt, Riccardo .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (10) :1296-1304
[5]   Microbiology and Mortality of Pediatric Febrile Neutropenia in El Salvador [J].
Gupta, Sumit ;
Bonilla, Miguel ;
Gamero, Mario ;
Fuentes, Soad L. ;
Caniza, Miguela ;
Sung, Lillian .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (04) :276-280
[6]   Etiology and Clinical Course of Febrile Neutropenia in Children With Cancer [J].
Hakim, Hana ;
Flynn, Patricia M. ;
Knapp, Katherine M. ;
Srivastava, Deo Kumar ;
Gaur, Aditya H. .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (09) :623-629
[7]   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[8]   The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients [J].
Klastersky, J ;
Paesmans, M ;
Rubenstein, EB ;
Boyer, M ;
Elting, L ;
Feld, R ;
Gallagher, J ;
Herrstedt, J ;
Rapoport, B ;
Rolston, K ;
Talcott, J .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :3038-3051
[9]   Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93 [J].
Lehrnbecher, T ;
Varwig, D ;
Kaiser, J ;
Reinhardt, D ;
Klingebiel, T ;
Creutzig, U .
LEUKEMIA, 2004, 18 (01) :72-77
[10]   Febrile episodes in children with cancer in the United Arab Emirates [J].
Mahmood, S ;
Revesz, T ;
Mpofu, C .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1996, 13 (02) :135-142